{"transactions":[{"id":4616428,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46395,"derivative":{"underlying":"Common Stock","underlying_shares":533},"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":4616427,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":263,"price":144.81,"value":38085.03,"ownership":{"direct":true},"balance_after":19522,"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":4616426,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":19785,"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":308402,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46928,"derivative":{"underlying":"Common Stock","underlying_shares":533},"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":308401,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":263,"price":121.48,"value":31949.24,"ownership":{"direct":true},"balance_after":19252,"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":308400,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":19515,"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":311752,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-03-12T20:22:25.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":31475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":31475,"derivative":{"exercise_price":148.56,"expiration_date":"2036-03-10","underlying":"Common Stock","underlying_shares":31475},"source":{"system":"sec-edgar","filing":"0001739515-26-000006","document":"wk-form4_1773346941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000006/wk-form4_1773346941.xml","form_type":"4"}},{"id":311751,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:22:25.000Z","date":"2026-03-10","kind":"grant","planned":false,"acquired":true,"shares":8415,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":47461,"derivative":{"underlying":"Common Stock","underlying_shares":8415},"source":{"system":"sec-edgar","filing":"0001739515-26-000006","document":"wk-form4_1773346941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000006/wk-form4_1773346941.xml","form_type":"4"}},{"id":311750,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-12T20:22:25.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2133,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":39046,"derivative":{"underlying":"Common Stock","underlying_shares":2133},"source":{"system":"sec-edgar","filing":"0001739515-26-000006","document":"wk-form4_1773346941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000006/wk-form4_1773346941.xml","form_type":"4"}},{"id":311749,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:22:25.000Z","date":"2026-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1063,"price":148.56,"value":157919.28,"ownership":{"direct":true},"balance_after":18982,"source":{"system":"sec-edgar","filing":"0001739515-26-000006","document":"wk-form4_1773346941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000006/wk-form4_1773346941.xml","form_type":"4"}},{"id":311748,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-12T20:22:25.000Z","date":"2026-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2133,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":20045,"source":{"system":"sec-edgar","filing":"0001739515-26-000006","document":"wk-form4_1773346941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000006/wk-form4_1773346941.xml","form_type":"4"}},{"id":312382,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-02T21:51:29.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":8530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors."}],"balance_after":17912,"source":{"system":"sec-edgar","filing":"0001739515-26-000004","document":"wk-form4_1772488286.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000004/wk-form4_1772488286.xml","form_type":"4"}},{"id":315535,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-05T22:56:33.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":false,"shares":16326,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested."}],"balance_after":41179,"derivative":{"underlying":"Common Stock","underlying_shares":16326},"source":{"system":"sec-edgar","filing":"0001739515-26-000002","document":"wk-form4_1767653790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000002/wk-form4_1767653790.xml","form_type":"4"}},{"id":315534,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-05T22:56:33.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":6944,"price":121.6,"value":844390.4,"ownership":{"direct":true},"balance_after":9382,"source":{"system":"sec-edgar","filing":"0001739515-26-000002","document":"wk-form4_1767653790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000002/wk-form4_1767653790.xml","form_type":"4"}},{"id":315533,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-01-05T22:56:33.000Z","date":"2026-01-02","kind":"exercise","planned":false,"acquired":true,"shares":16326,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":16326,"source":{"system":"sec-edgar","filing":"0001739515-26-000002","document":"wk-form4_1767653790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000002/wk-form4_1767653790.xml","form_type":"4"}},{"id":324079,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2025-03-12T22:04:26.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":37710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a four-year vesting schedule.  25% vest on the first anniversary of the date of grant.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":37710,"derivative":{"exercise_price":117.21,"expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":37710},"source":{"system":"sec-edgar","filing":"0001127602-25-009263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009263/form4.xml","form_type":"4"}},{"id":324078,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-03-12T22:04:26.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8530,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":57505,"derivative":{"underlying":"Common Stock","underlying_shares":8530},"source":{"system":"sec-edgar","filing":"0001127602-25-009263","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225009263/form4.xml","form_type":"4"}},{"id":327608,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"officer":true,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T23:38:02.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":48975,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% will vest on the anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three year vesting schedule.  33.33% will vest on the anniversary of the date of grant until fully vested."}],"balance_after":48975,"derivative":{"underlying":"Common Stock","underlying_shares":48975},"source":{"system":"sec-edgar","filing":"0001127602-25-000548","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760225000548/form4.xml","form_type":"4"}},{"id":3534805,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Common Stock","published_at":"2019-05-08T20:32:32.000Z","date":"2019-05-07","kind":"tax_withholding","acquired":false,"shares":4322,"price":33.46,"value":144614.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to cover tax obligation from settlement of vested restricted stock units."}],"balance_after":85678,"source":{"system":"sec-edgar","filing":"0001209191-19-028232","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919119028232/doc4.xml","form_type":"4"}},{"id":3576223,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Common Stock","published_at":"2019-03-27T21:17:46.000Z","date":"2019-03-26","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 50% of the shares on March 26, 2020 and 50% of the shares on March 26, 2021, subject to the reporting person's continuous service."}],"balance_after":90000,"source":{"system":"sec-edgar","filing":"0001209191-19-021442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919119021442/doc4.xml","form_type":"4"}},{"id":3667582,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-08T21:26:38.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the stock option vest and become exercisable each month following February 6, 2019, subject to the reporting person's continuous service."}],"balance_after":50000,"derivative":{"exercise_price":38.47,"expiration_date":"2029-02-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-008518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919119008518/doc4.xml","form_type":"4"}},{"id":3667581,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Common Stock","published_at":"2019-02-08T21:26:38.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in four equal annual installments on each of the first, second, third and fourth anniversaries of the grant date, subject to the reporting person's continuous service."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001209191-19-008518","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919119008518/doc4.xml","form_type":"4"}},{"id":3943957,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-07T23:02:20.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on May 7, 2019 and the remaining shares vest in equal monthly installments over the following 36 months."}],"balance_after":85000,"derivative":{"exercise_price":42.05,"expiration_date":"2025-05-06","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-18-028449","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919118028449/doc4.xml","form_type":"4"}},{"id":3943956,"issuer":{"id":6828,"kind":"organization","name":"Atara Biotherapeutics, Inc.","symbol":"ATRA"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Global Head of R&D"}}],"security":"Common Stock","published_at":"2018-05-07T23:02:20.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"25% of the shares subject to restricted stock units vest on May 7, 2019 and the remaining shares vest in equal annual installments over the following 3 years."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001209191-18-028449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1604464/000120919118028449/doc4.xml","form_type":"4"}}]}